Riskpilot← Back to searchSign inGet full accessTANDPROTETIKEREN, HORSENS ApS
APSActiveCVR 26090555Løvenørnsgade 15, 2.Dental practice care activities · NACE 8623Est. 20013 employeeswww.tpt.dk
Revenue 2024
DKK 1,5M
+15% vs 2023
EBITDA margin
31.2%
+20% vs 2023
Equity ratio
68.2%
Financial strength
Net profit 2024
DKK 384K
+24% vs 2023
| Revenue | DKK 1,5M | +15% |
| EBITDA | DKK 483K | +20% |
| Net profit | DKK 384K | +24% |
| Total assets | DKK 1,1M | +14% |
| Equity | DKK 723K | +13% |
| Employees | 3 | — |
Legal name
TANDPROTETIKEREN, HORSENS ApS
CVR number
26090555
Legal form
Anpartsselskab
NACE code
8623 · Dental practice care activities
Founded
21. juni 2001
Share capital
DKK 125.000
Employees
3 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at drive klinisk tandteknisk virksomhed samt i forbindelse hermed stående virksomhed.
Address
Løvenørnsgade 15, 2.
Phone
+4575625473
Email
evin.celal@tpt.dk
Website
www.tpt.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1.083 | 923 | 1.205 | 1.341 | 1.546 |
| Staff expenses | -839 | -806 | -930 | -938 | -1.063 |
| EBITDA | 244 | 117 | 275 | 403 | 483 |
| Depreciation & amort. | -1 | -12 | -12 | -11 | -0 |
| EBIT | 243 | 105 | 263 | 392 | 483 |
| Net financials | -3 | -7 | -1 | 4 | 11 |
| Profit before tax | 240 | 98 | 262 | 397 | 493 |
| Tax | 53 | 23 | 58 | 88 | 110 |
| Net profit | 186 | 75 | 204 | 308 | 384 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 986 | 942 | 776 | 930 | 1.060 |
| Equity | 652 | 527 | 531 | 639 | 723 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 334 | 415 | 245 | 291 | 337 |
| Total debt | 334 | 415 | 245 | 291 | 337 |
EBITDA margin
31.2%
This company
15.8%
Market median
+97% vs market
20202024
Equity ratio
68.2%
This company
38.2%
Market median
+79% vs market
20202024
Return on equity
53.1%
This company
18.4%
Market median
+189% vs market
20202024
Net profit margin
24.8%
This company
8.1%
Market median
+206% vs market
20202024
Asset turnover
1.46×
This company
1.12×
Market median
+30% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EC Management | Management | 2010 |
CS Founder | Founder | 2001 |
| Former (1) | ||
MW Management | Management | 2010 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairman | 2012 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 | |
| Company | 25–33.32% | 25–33.32% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EVIN CELAL HOLDING ApS
TANDPROTETIKEREN, HORSENS ApS Board members of TANDPROTETIKEREN, HORSENS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Wiernek | Management | 0 companies |
| Evin Celal | Management | 0 companies |
| Connie Samson | Founder | 0 companies |
| Sven Erik Sørensen | Chairman | 0 companies |